Back to Search Start Over

672P Phase I/II trial of RVU120 (SEL120), CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors.

Authors :
Dziadziuszko, R.
Lugowska, I.
Garralda, E.
Rojas Laimito, K.I.
Rzymski, T.
Dudziak, R.
Littlewood, P.
Nogai, H.
Boni, V.
Fuentes Antras, J.
Alonso, G.
Saavedra Santa Gadea, O.
Kuklík, R.
Source :
Annals of Oncology. 2023 Supplement 2, Vol. 34, pS472-S472. 1p.
Publication Year :
2023

Subjects

Subjects :
*METASTASIS
*TUMORS

Details

Language :
English
ISSN :
09237534
Volume :
34
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
173098728
Full Text :
https://doi.org/10.1016/j.annonc.2023.09.1858
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details